Cellectis S.A. Share Price Today: Live Updates & Key Insights
Cellectis S.A. share price today is $3.35, up -4.02%. The stock opened at $3.37 against the previous close of $3.48, with an intraday high of $3.42 and low of $3.26.
Cellectis S.A. Share Price Chart
Cellectis S.A.
Cellectis S.A. Share Price Performance
Cellectis S.A. Institutional Holdings
Cellectis S.A. Market Status
Cellectis S.A. Fundamentals
Market Cap 335.97 M
PB Ratio 3.3438
PE Ratio 0.0
Enterprise Value 245.03 M
Total Assets 383.54 M
Volume 103093
Cellectis S.A. Company Financials
About Cellectis S.A. & investment objective
Company Information Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company was founded in 1999 and is headquartered in Paris, France.
Organisation Biotechnology
Employees 216
Industry Biotechnology
CEO Dr. Andre Choulika Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Cellectis S.A. FAQs
What is the share price of Cellectis S.A. today?
The current share price of Cellectis S.A. is $3.35.
Can I buy Cellectis S.A. shares in India?
Yes, Indian investors can buy Cellectis S.A. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Cellectis S.A. shares in India?
You can easily invest in Cellectis S.A. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Cellectis S.A. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Cellectis S.A..
Can I buy fractional shares of Cellectis S.A.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Cellectis S.A.?
Cellectis S.A. has a market cap of $335.97 M.
In which sector does Cellectis S.A. belong?
Cellectis S.A. operates in the Biotechnology sector.
What documents are required to invest in Cellectis S.A. stocks?
To invest, you typically need:
What is the PE and PB ratio of Cellectis S.A.?
The PE ratio of Cellectis S.A. is N/A and the PB ratio is 3.34.